Prolisa™ Quantitative Anti-SARS-CoV-2 IgG EIA

Prolisa™ Quantitative Anti-SARS-CoV-2 IgG EIA is intended for the quantitative detection of human immunoglobulins G (IgG) against SARS-CoV-2 in human serum and K2-EDTA, lithium heparin and citrate plasma. It works as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating antibody titers of infection and/or vaccination.

Kit Contains:
PL.2116 Coated and Stabilized plate (1)
PL.2104 Substrate Solution (14 mL)
PL.2117 Anti-human IgG HRP Solution (14 mL)
PL.2118 Sample Diluent (20ml)
PL.2119 20X Wash Buffer (25ml x 2)
PL.2120 Stop Solution (14ml)
PL.2121 to PL.2128 IgG standards S1 – S8 (0.7 mL each)
Plate Sealer (3)
Instruction for use (1)
Label indicating BAU/mL values of IgG standards (1)

This kit is currently for Research Use Only.